VERX Stock Recent News
VERX LATEST HEADLINES
Vertex (VERX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Vertex enjoys a monopoly that could soon grow stronger. The company could have multiple potential blockbuster drugs on the way.
MENLO PARK, Calif.--(BUSINESS WIRE)-- #FDA--FDA approves U.S. pivotal trial of Jupiter Endovascular pulmonary embolism system with Endoportal Control technology.
Vertex (VERX) could produce exceptional returns because of its solid growth attributes.
Vertex Pharmaceuticals CRISPR and Moderna are included in this Analyst Blog.
LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassemia (TDT) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY™ (exagamglogene autotemcel), from today. The reimbursement agreement comes as the National Institute for Health and Care Excellence (NICE) issues positive guidance recommending CASGEVY's use in the NHS. The United Kingdom (U.K.) Medicines and Healthcare p.
Vertex, Inc. (NASDAQ:VERX ) Q2 2024 Results Conference Call August 7, 2024 8:30 AM ET Company Participants Joe Crivelli - VP, IR David DeStefano - President and CEO John Schwab - CFO Conference Call Participants Brad Reback - Stifel Joshua Reilly - Needham Rob Oliver - Baird Chris Quinter - Morgan Stanley Steve Enders - Citi Daniel Jester - BMO Capital Markets Adam Hotchkiss - Goldman Sachs Alex Sklar - Raymond James Patrick Walravens - Citizens JMP Securities Jake Roberge - William Blair Operator Good morning. And welcome to the Vertex Inc. Second Quarter 2024 Earnings Conference Call.
Vertex (VERX) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.08 per share a year ago.
Delivering a Seamlessly Connected Global Platform to Manage Continuous Compliance Delivering a Seamlessly Connected Global Platform to Manage Continuous Compliance
KING OF PRUSSIA, Pa., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its second quarter ended June 30, 2024.